Search research articles
Contact Us
Filters
Showing results (131-140 of 199) with videos related to
Page
of 20
Sort By:
The Journal of Clinical Investigation
|
December 10, 2020
Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models
Wenqing Li, Robert Shenkar, Mathew R Detter, et al.
Blood
|
November 17, 2018
Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice
Miguel Alejandro Lopez-Ramirez, Angela Pham, Romuald Girard, et al.
Stroke
|
February 1, 2024
Association Between Hematoma Volume and Risk of Subsequent Ischemic Stroke: A MISTIE III and ATACH-2 Analysis
William Harris, Jed H Kaiser, Vanessa Liao, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
August 10, 2017
Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage
Hussein A Zeineddine, Romuald Girard, Ying Cao, et al.
Neurosurgery
|
April 8, 2017
Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel
Amy Akers, Rustam Al-Shahi Salman, Issam A Awad, et al.
Neurosurgery
|
April 13, 2017
Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial
Maged D Fam, Daniel Hanley, Agnieszka Stadnik, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
July 12, 2023
Underlying intracranial atherosclerotic disease is associated with worse outcomes in acute large vessel occlusion undergoing endovascular thrombectomy
Tareq Kass-Hout, Rami Z Morsi, Sonam Thind, et al.
Biomarkers in Medicine
|
February 11, 2016
Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease
Romuald Girard, Omaditya Khanna, Robert Shenkar, et al.
The Journal of Clinical Investigation
|
October 1, 2021
Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models
Wenqing Li, Robert Shenkar, Mathew R Detter, et al.
Neurosurgery
|
January 31, 2015
Bleeding and infection with external ventricular drainage: a systematic review in comparison with adjudicated adverse events in the ongoing Clot Lysis Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III (CLEAR-III IHV) trial
Mahua Dey, Agnieszka Stadnik, Fady Riad, et al.
Page
of 20
Search research articles
Search
Showing results (131-140 of 199) with videos related to
Sort By:
Page
of 20
The Journal of Clinical Investigation
|
December 10, 2020
Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models
Wenqing Li, Robert Shenkar, Mathew R Detter, et al.
Blood
|
November 17, 2018
Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice
Miguel Alejandro Lopez-Ramirez, Angela Pham, Romuald Girard, et al.
Stroke
|
February 1, 2024
Association Between Hematoma Volume and Risk of Subsequent Ischemic Stroke: A MISTIE III and ATACH-2 Analysis
William Harris, Jed H Kaiser, Vanessa Liao, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
August 10, 2017
Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage
Hussein A Zeineddine, Romuald Girard, Ying Cao, et al.
Neurosurgery
|
April 8, 2017
Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel
Amy Akers, Rustam Al-Shahi Salman, Issam A Awad, et al.
Neurosurgery
|
April 13, 2017
Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial
Maged D Fam, Daniel Hanley, Agnieszka Stadnik, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
July 12, 2023
Underlying intracranial atherosclerotic disease is associated with worse outcomes in acute large vessel occlusion undergoing endovascular thrombectomy
Tareq Kass-Hout, Rami Z Morsi, Sonam Thind, et al.
Biomarkers in Medicine
|
February 11, 2016
Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease
Romuald Girard, Omaditya Khanna, Robert Shenkar, et al.
The Journal of Clinical Investigation
|
October 1, 2021
Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models
Wenqing Li, Robert Shenkar, Mathew R Detter, et al.
Neurosurgery
|
January 31, 2015
Bleeding and infection with external ventricular drainage: a systematic review in comparison with adjudicated adverse events in the ongoing Clot Lysis Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III (CLEAR-III IHV) trial
Mahua Dey, Agnieszka Stadnik, Fady Riad, et al.
Page
of 20